Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators
Dutch Cancer Society, Re-turn
Enrollment target
~140 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated November 2024